COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,610 Articles (22,913 medRxiv, 8,697 bioRxiv)

Most recent first Previous |  Page 768: Articles 7671-7680  | Next

Evidence of recent Epstein-Barr virus reactivation in individuals experiencing Long COVID
Peluso, M. J., Deveau, T.-M., Munter, S. E., Ryder, D., Buck, A., Lu, S., Goldberg, S. A., Hoh, R., Tai, V., Torres, L., Iyer, N. S., Deswal, M., Ngo, L. H., Buitrago, M., Rodriguez, A., Chenna, J. Y., Yee, B. C., Chenna, A., Winslow, J. W., Petropoulos, C. J., Deitchman, A. N., Hunt, P. W., Durstenfeld, M. S., Hsue, P. Y., Kelly, J. D., Martin, J. N., Deeks, S. G., Henrich, T. J.
10.1101/2022.06.21.22276660 — Posted: 2022-06-22
COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022
Wang, L., Berger, N. A., Davis, P. B., Kaelber, D. C., Volkow, N., Xu, R.
10.1101/2022.06.21.22276724 — Posted: 2022-06-22
Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: parameter estimates, sensitivity and the eclipse phase profile
Korosec, C. S., Betti, M. I., Dick, D. W., Ooi, H. K., Moyles, I. R., Wahl, L. M., Heffernan, J. M.
10.1101/2022.06.20.22276662 — Posted: 2022-06-22
Persistence of SARS-CoV-2 omicron variant in children and utility of rapid antigen testing as an indicator of culturable virus
Lohse, Z. M., Shapiro, J. J., Lednicky, J. A., Cash, M. N., Jun, I., Mavian, C., Tagliamonte, M. S., Saleem, C., Yang, Y., Nelson, E. J., Salemi, M., Ryan, K. A., Morris, J. G.
10.1101/2022.06.21.22276668 — Posted: 2022-06-22
Impact of COVID-19 vaccination on long COVID: a systematic review and meta-analysis
Byambasuren, O., Stehlik, P., Clark, J., Alcorn, K., Glasziou, P.
10.1101/2022.06.20.22276621 — Posted: 2022-06-22
Analysis of Whole-Genome Sequencing of SARS-CoV-2 Reveals Recurrent Mutations among Iranian Patients
Abbasian, M. H., Mahdavi, B., Mahmanzar, M., Tokhanbigli, S., Mollapour Sisakht, M., Moradi, B., Rahimian, K., Najmabadi, H.
10.1101/2022.06.20.22276625 — Posted: 2022-06-22
The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: a scoping review of systematic reviews and meta-analyses
Tope, P. R., Farah, E., Ali, R., El-Zein, M., Miller, W. H., Franco, E. L.
10.1101/2022.06.21.22276569 — Posted: 2022-06-22
The interaction between coping styles with relationship breakdowns, loss, and conflict and the frequency of self-harm thoughts and behaviours: a longitudinal analysis of 21,581 UK adults
Paul, E., Fancourt, D.
10.1101/2022.06.21.22276696 — Posted: 2022-06-22
Naturally-acquired Immunity Dynamics against SARS-CoV-2 in Children and Adolescents
Patalon, T., Saciuk, Y., Ohayon Hadad, H., Perez, G., Peretz, A., Ben-Tov, A., Gazit, S.
10.1101/2022.06.20.22276650 — Posted: 2022-06-21
A Bayesian hierarchical approach to account for reporting uncertainty, variants of concern and vaccination coverage when estimating the effects of non-pharmaceutical interventions on the spread of infectious diseases
Rehms, R., Ellenbach, N., Rehfuess, E. A., Burns, J., Mansmann, U., Hoffmann, S.
10.1101/2022.06.20.22276652 — Posted: 2022-06-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).